Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
160 Health InternationalHKSE:02656 -2.87%8 EV-to-FCF is -24.94 as of Aug. 19, 2026. GuruFocus rates HKSE:02656 with a GF Score™ of 8/100. The stock has 5 warning signs investors should review. Among 68 Medical Distribution companies, 160 Health International ranks worse than 1470586.76% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, 160 Health International's Enterprise Value is HK$3,265.9 Mil.
160 Health International's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-130.9 Mil. Therefore, 160 Health International's EV-to-FCF for today is -24.94.
The historical rank and industry rank for 160 Health International's EV-to-FCF or its related term are showing as below:
HKSE:02656'
s EV-to-FCF Range Over the Past 10 Years
Min: -324.88 Med: -154.96 Max: -20.43
Current: -24.94
During the past 4 years, the highest EV-to-FCF of 160 Health International was -20.43. The lowest was -324.88. And the median was -154.96.
HKSE:02656's EV-to-FCF is ranked worse than 100% of 68
companies
in the Medical Distribution industry
Industry Median: 15.955
vs HKSE:02656: -24.94
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
160 Health International (HKSE:02656) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
160 Health International's PE Ratio (TTM) for today is calculated as:
160 Health International's share price for today is HK$9.635.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 160 Health International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.264.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
160 Health International EV-to-FCF Related Terms
160 Health International EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, 160 Health International's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
160 Health International EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, 160 Health International's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where 160 Health International's EV-to-FCF falls into.
160 Health International's current Enterprise Value is HK$3,265.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 160 Health International's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-130.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
160 Health International (HKSE:02656) has a EV-to-FCF of -24.94 as of Aug. 19, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on 160 Health International and its competitors. According to the industry distribution chart, 160 Health International ranks #999999 out of 68 companies in the Medical Distribution industry.
Is 160 Health International's EV-to-FCF too high?
160 Health International's current EV-to-FCF is -24.94. Based on the distribution chart, 160 Health International ranks #999999 out of 68 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, 160 Health International has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does 160 Health International's EV-to-FCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, 160 Health International ranks #999999 out of 68 companies for EV-to-FCF. This places 160 Health International in the lower half of its industry. The industry median EV-to-FCF is 15.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 15.96, based on 68 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on 160 Health International and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 15.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 160 Health International's current EV-to-FCF is -24.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 160 Health International stock overvalued right now?
160 Health International (HKSE:02656) has a current EV-to-FCF of -24.94. The current EV-to-FCF is -24.94. 160 Health International's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For 160 Health International (HKSE:02656), the current EV-to-FCF is -24.94 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
160 Health International Ltd is an experienced pharmaceutical and healthcare product wholesaler and a digital healthcare integrated service provider in China. The company offers a wide assortment of high-quality pharmaceutical and healthcare products under both wholesale and retail models, to address a spectrum of customer needs. In addition, through its online healthcare and wellness service platform, Healthcare 160 Platform. It also provide digital healthcare and wellness solutions, empowering each Platform Participants, including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, throughout the healthcare value chain and driving the digital transformation of China's healthcare and wellness industry.
8GF Score
Get the complete analysis for HKSE:02656
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02656 has been successfully added to your 
